The Indiana Budget Committee last month approved $50 million in funding for bond financing of a water pipeline from ...
Indianapolis-based Eli Lilly and Co. on Thursday announced plans to spend $1.8 billion on two of its manufacturing sites in Ireland to boost production of medicines for Alzheimers ...
forcing the company to invest heavily to increase production. Eli Lilly has invested more than $20 billion to buy, build and expand manufacturing plants in the U.S. and Europe since 2020. "These ...
Eli Lilly has again upped the ante in scaling up its manufacturing footprint, this time revealing an investment totaling $1.8 billion to expand production capacity at two plants in Ireland. | Eli ...
Sold under the brand names Mounjaro and Zepbound, tirzepatide has been an incredible growth driver for Eli Lilly. In 2022 -- ...
(Reuters) - Eli Lilly (NYSE:LLY) and Co said on Monday it will invest an additional $1.6 billion at its two new manufacturing sites in Indiana, United States to support the... Eli Lilly and ...
Nearly $1 billion will go toward expanding a facility that last year began making medicines for the company's new diabetes and obesity treatments.
Indianapolis-based Eli Lilly and Co. is ... at pharmacy-made weight-loss drugs. Lilly is investing heavily in expanding its highly regulated manufacturing plants, which haven’t been able to ...
Wells Fargo analyst Mohit Bansal assigned a Buy rating on Eli Lilly & Co (LLY – Research Report) yesterday and set a price target of ...
Eli Lilly said it will spend $1.8 billion to boost production in Ireland of its popular diabetes and weight-loss drugs, along with ingredients for its recently approved Alzheimer’s treatment, Kisunla.
(Reuters) - Some Eli Lilly (NYSE:LLY) and Co employees have requested transfers from the drugmaker's Indiana operations after the U.S. state's lawmakers approved a ...
Eli Lilly is investing heavily in expanding its highly regulated manufacturing plants, which haven’t been able to keep up with demand for its most sought-after drugs, he explained.